Can Angiogenesis be a Target of Treatment for Ribavirin Associated Hemolytic Anemia?

Yonem O., Arslan S., Sokmensuer C., Salmanzade S.

HEPATO-GASTROENTEROLOGY, cilt.57, ss.562-566, 2010 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 57
  • Basım Tarihi: 2010
  • Dergi Adı: HEPATO-GASTROENTEROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.562-566
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background/Aims: Recently ribavirin has been found to inhibit angiogenesis and a number of angiogenesis inhibitors such as sunitinib and sorafenib have been found to cause acute hemolysis. We aimed to investigate whether there is a relation between hemoglobin, haptoglobin and angiogenesis soluble markers which are modifiable and can help in developing strategies against anemia.